Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FFAR1 | O14842 | 4/20 | 0.53 |
| ▸ | PPARG | P37231 | 8/20 | 0.52 |
| ▸ | PPARA | Q07869 | 7/20 | 0.52 |
| ▸ | PPARD | Q03181 | 4/20 | 0.46 |
| ▸ | SPHK2 | Q9NRA0 | 1/20 | 0.44 |
| ▸ | SMPD1 | P17405 | 1/20 | 0.43 |
| ▸ | MAOB | P27338 | 3/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4748565 | 0.88 | PPARG (0.60) | FFAR1PPARGPPARAPPARDSPHK2 | |
| SCHEMBL4746718 | 0.88 | FFAR1 (0.50) | FFAR1PPARGPPARAPPARDSMPD1 | |
| SCHEMBL9264706 | 0.87 | PPARG (0.51) | FFAR1PPARGPPARAPPARDSPHK2 | |
| SCHEMBL4744035 | 0.86 | PPARA (0.65) | FFAR1PPARGPPARA | |
| SCHEMBL4747385 | 0.84 | FFAR1 (0.56) | FFAR1PPARGPPARAPPARD | |
| SCHEMBL4747041 | 0.84 | FFAR1 (0.72) | FFAR1PPARGPPARA | |
| SCHEMBL9261947 | 0.82 | PPARG (0.49) | FFAR1PPARGPPARAPPARDSPHK2 | |
| SCHEMBL9089772 | 0.82 | PPARG (0.53) | FFAR1PPARGPPARAPPARDSMPD1 | |
| SCHEMBL9261466 | 0.82 | PPARG (0.47) | FFAR1PPARGPPARAPPARDSPHK2 | |
| SCHEMBL9261471 | 0.82 | PPARG (0.47) | FFAR1PPARGPPARAPPARDSPHK2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2008117982-A1 | HETEROCYCLIC CARBOXYLIC ACID DERIVATIVES AND PHARMACEUTICAL COMPOSITION FOR INHIBITING LIPID ACCUMULATION CONTAINING SAME | CRYSTAL GENOMICS, INC. (KR) | 2008-10-02 | — | — | WO | disclosed |